Posted in | News | Business | Fibers

Holmen to Shut Down Smaller Printing Paper Production Machine in Madrid

Holmen Paper (STO:HOLMA)(STO:HOLMB) will be shutting down production of printing paper at the smaller paper machine in Madrid.

This equates to almost 10 per cent of the business area’s production capacity. Approximately 170 employees will be affected.

“We’ve been working to make PM 61 profitable for a long time now, both through cost savings and the development of new products. Our employees have made an excellent job, but we’ve been forced to concede that it’s not enough,” comments Magnus Hall, President and CEO of Holmen. “The machine is not sufficiently competitive to justify continued operation either in the short or long term. The decision is part of a strategy to focus our business on printing paper segments where Holmen Paper has high competitiveness.”

PM 61 has a capacity of 170 000 tonnes per year and produces coated magazine paper (LWC) as well as improved newsprint to a lesser extent. In recent years, the machine has seen low capacity utilisation.

Holmen acquired the mill in Madrid in 2000, by which time PM 61 had been operating for two years. In 2005 the mill expanded with the addition of PM 62, a new paper machine for large-scale production of newsprint. Paper manufacture in Madrid is based 100 per cent on recovered paper as the raw material and the plant has its own energy supply in the form of a gas-fired CHP. After the closure, PM 62 will give the mill a capacity of 330 000 tonnes.

The financial consequences of the closure are outlined in the year-end report for 2010.

In its capacity as issuer, Holmen AB is releasing the information in this press release in accordance with Chapter 17 of the Swedish Securities Market Act (2007:528). The information was distributed to the media for publication at 12.03 CET on Wednesday 2 February 2011.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.